CClinicalTrials.gg
Not yet recruitingNCT06792279Updated Jan 24, 2025

Detection of Muscle Quality in Children - Protocol for a Validation Study

An observational study in Ultrasonography, sponsored by Charles University, Czech Republic. Not yet recruiting at 1 site in Czech Republic. Open to participants aged 10 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-24.

Sponsored by Charles University, Czech Republic · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
120
Ages
10 Years to 14 Years
Sex
All
01

Study summary

The goal of this observational study is to evaluate the validity and reliability of ultrasound echo intensity (EI) as a diagnostic tool for assessing muscle quality in children aged 10-14 years, including normal-weight, obese, and trained young athletes. The main questions it aims to answer are:

Can EI reliably and accurately measure muscle quality in children when validated against gold-standard techniques like DXA and isokinetic dynamometry? What are the age-, sex-, and fitness-specific benchmarks for EI to differentiate between normal and pathological muscle quality?

02

Conditions studied

  • Ultrasonography
03

In context

Lead sponsor

Charles University, Czech Republic is the lead sponsor of 220 studies on the registry; 76 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Sixty boys and sixty girls aged 10-14 years, evenly distributed as follows: normal-weight children, trained young athletes (≥3 training sessions per week), and obese children according to BMI

Inclusion criteria

  • Generally healthy children

Exclusion criteria

Exclusion Criteria:

  • Acute illnesses
  • Chronic or acute diseases of the endocrine or musculoskeletal systems
  • Post-traumatic conditions
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Echo intensity of the vastus lateralis (VL) and rectus femoris (RF) muscles

    Echo intensity will be measured by greyscale analysis derivered from ultrasound imaging.

    Time frame: Through study completion, an average of 1 year

Secondary outcomes

  1. Skeletal Muscle Mass

    Measured using DXA (Horizon DXA platform, Hologic)

    Time frame: Through study completion, an average of 1 year

  2. Muscle Strength

    Assessed via isokinetic and isometric knee extensor strength using a Humac Norm isokinetic dynamometer

    Time frame: Through study completion, an average of 1 year

07

Study locations

1 site
  • Faculty of Physical Education and Sport Charles University
    Prague, 16200, Czech Republic
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06792279
Lead sponsor
Charles University, Czech Republic
Responsible party
Michal Šteffl (ass. prof., Charles University, Czech Republic) — Principal investigator
First posted
Jan 24, 2025
Start date
Mar 1, 2025 (estimated)
Primary completion
Mar 31, 2026 (estimated)
Completion
Mar 31, 2026 (estimated)
Last update
Jan 24, 2025

Study contacts

Michal Steffl, PhD
Contact
michal.steffl@ftvs.cuni.cz
+420778701882

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion